Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: A systematic review

被引:16
|
作者
Sherman K.A. [1 ,2 ]
Miller S.M. [3 ]
Shaw L.-K. [1 ]
Cavanagh K. [1 ]
Sheinfeld Gorin S. [4 ]
机构
[1] Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney
[2] Westmead Breast Cancer Institute, Westmead Hospital, Sydney, NSW
[3] Psychosocial and Behavioral Medicine Department, Fox Chase Cancer Center/Temple Health, Philadelphia, PA
[4] National Cancer Institute (SAIC), Bethesda, MD
基金
美国国家卫生研究院;
关键词
African American; BRCA1/2; Breast cancer; Genetic testing; Review;
D O I
10.1007/s12687-013-0164-y
中图分类号
学科分类号
摘要
Breast cancer is a significant health concern for African American women. Nonetheless, uptake of genetic risk assessment (including both genetic counseling and testing) for breast cancer gene mutations among these populations remains low. This paper systematically reviews cognitive (i.e., beliefs) and affective (i.e., emotions) factors influencing BRCA1/2 genetic risk assessment among African American women as well as psychosocial interventions to facilitate informed decision making in this population. A systematic search of CINAHL, PubMed, and PsycINFO was undertaken, yielding 112 published studies. Of these, 18 met the eligibility criteria. African American woman are likely to participate in genetic risk assessment if they are knowledgeable about cancer genetics, perceive a high risk of developing breast cancer, have low expectancies of stigmatization from medical professionals, view themselves as independent from family, and have fatalistic beliefs and a future temporal orientation. Anticipated negative affective responses, such as an inability to "handle" the results of testing, are barriers to uptake. Specific perceptions, beliefs, and emotional factors are associated with genetic risk assessment among African American women. Understanding these factors is key in the development of interventions to facilitate informed decision making in this population. © 2013 Springer-Verlag.
引用
收藏
页码:89 / 98
页数:9
相关论文
共 50 条
  • [31] BRCA1 variants in a family study of African-American and Latina women
    McKean-Cowdin, R
    Feigelson, HS
    Xia, LY
    Pearce, CL
    Thomas, DC
    Stram, DO
    Henderson, BE
    HUMAN GENETICS, 2005, 116 (06) : 497 - 506
  • [32] Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
    Xia, Yue Yin
    Gronwald, Jacek
    Karlan, Beth
    Lubinski, Jan
    McCuaig, Jeanna M.
    Brooks, Jennifer
    Moller, Pal
    Eisen, Andrea
    Sun, Sophie
    Senter, Leigha
    Bordeleau, Louise
    Neuhausen, Susan L.
    Singer, Christian F.
    Tung, Nadine
    Foulkes, William D.
    Sun, Ping
    Narod, Steven A.
    Kotsopoulos, Joanne
    GYNECOLOGIC ONCOLOGY, 2022, 164 (03) : 514 - 521
  • [33] Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    McCuaig, Jeanna M.
    Karlan, Beth Y.
    Eisen, Andrea
    Tung, Nadine
    Bordeleau, Louise
    Senter, Leigha
    Eng, Charis
    Couch, Fergus
    Fruscio, Robert
    Weitzel, Jeffrey N.
    Olopade, Olufunmilayo
    Singer, Christian F.
    Pal, Tuya
    Foulkes, William D.
    Neuhausen, Susan L.
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    Huzarski, Tomasz
    Cybulski, Cezary
    Rosen, Barry
    Sweet, Kevin
    Zakalik, Dana
    Wood, Marie
    McKinnon, Wendy
    Elser, Christine
    Wiesner, Georgia
    Friedman, Eitan
    Meschino, Wendy
    Snyder, Carrie
    Metcalfe, Kelly
    Poll, Aletta
    Warner, Ellen
    Kim, Raymond
    Armel, Susan
    Demsky, Rochelle
    Ainsworth, Peter
    Steele, Linda
    Saal, Howard
    Serfas, Kim
    Panchal, Seema
    Cullinane, Carey A.
    Reilly, Robert E.
    Blum, Joanne L.
    Kwong, Ava
    Rayson, Daniel
    Ramon y Cajal, Teresa
    Dungan, Jeffrey
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 820 - 826
  • [34] Development of a targeted BRCA1/BRCA2 mutation screening panel for African-American women.
    Gayol, L
    Ahearn, ME
    Fernandez, L
    Estrella, E
    Mirhashemi, R
    Arena, JF
    Baumbach, L
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 233 - 233
  • [35] Uptake of free BRCA1/2 testing in women at risk for BRCA1/2 germline mutations.
    Shannon, KM
    Lubratovich, ML
    Finkelstein, D
    Goggins, W
    Haber, DA
    Seiden, MV
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A322 - A322
  • [36] Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations
    Powell, C. Bethan
    Alabaster, Amy
    Armstrong, Mary Anne
    Stoller, Nicole
    Raine-Bennett, Tina
    GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 489 - 493
  • [37] Factors Influencing Breast Cancer Genetic Testing Among High Risk African American Women: A Systematic Review Abstracts
    Spencer, Shirley Ann
    Rodgers, Carolyn
    Coffey, Vickii
    INTERNET JOURNAL OF ALLIED HEALTH SCIENCES AND PRACTICE, 2019, 17 (04):
  • [38] Risk management decisions in women with BRCA1 and BRCA2 mutations
    Morgan, Rosemary
    Brown, Audrey
    Hamman, Kelly Jo
    Sampson, Jone
    Naik, Arpana
    Massimino, Kristen
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 899 - 903
  • [39] Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations
    Powell, B.
    Alabaster, A.
    Armstrong, M. A.
    Stoller, N.
    Raine-Bennett, T. R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 201 - 201
  • [40] Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women
    Thompson, HS
    Valdimarsdottir, HB
    Duteau-Buck, C
    Guevarra, J
    Bovbjerg, DH
    Richmond-Avellaneda, C
    Amarel, D
    Godfrey, D
    Brown, K
    Offit, K
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (12) : 1579 - 1585